Objective: Nonsteroidal anti-inflammatory drugs are considered the mainstay in the treatment of renal colic. Nonsteroidal anti-inflammatory drugs are contraindicated in patients with renal failure and are not recommended in patients with certain diseases. In these cases other analgesics should be used. The aim of our study was to compare the analgesic efficacy of intramuscular Diclofenac and Tramadol in the treatment of renal colic in our emergency department.
INTRODUCTION
Renal colic is a common presenting clinical problem in the emergency departments (ED). Usually it refers to symptomatic nephrolithiasis. The prevalence of renal colic in the general population is 10% [1] . The classic clinical picture is characterized by acute flank pain which sometimes fluctuates and radiates to the groin and scrotum in males [2] . The main issue in the management of these patients in the ED is sufficient pain control. Pain medications given for symptomatic relief is the only treatment needed in about 90% of patients [3, 4] .
The failure of conservative treatment depends mainly on two parameters: stone size and stone location in the urinary tract [5] . There is a negative correlation between stone size and its spontaneous passage. Stones > 4mm rarely pass alone [6] . This is also true for stones in the proximal ureter that tend to impact in the ureter and less frequently pass spontaneously as compared to stones located in the distal ureter [7] .
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The pharmacological treatment for pain in patients with renal colic depends on its intensity: simple analgesia like paracetamol and dypirone helps in very mild cases. In moderate to severe pain, stronger analgesia is needed. Nonsteroid anti-inflammatory drugs (NSAIDs) and opiates are good options [9] .
NSAIDs have the possible advantage of decreasing ureteral smooth muscle tone, thereby directly treating the mechanism by which pain is thought to occur [10] . NSAIDs are contraindicated in patients with renal failure and are not recommended in patients with certain diseases which could involve the kidney [11] . In these cases other analgesics should be used. Diclofenac is a common NSAID used in patients with renal colic.
Opiates as Morphine and Pethidine (meperidine, Demerol) are effective in pain management but could lead to respiratory depression or even respiratory arrest in about 10 % and 1% of cases respectively. These statistics in general are not necessarily relevant to the population in our clinical trial [12] . Thus, patients given these drugs need close monitoring which could be a problem in a crowded ED.
Tramadol is a semi-synthetic opiate which has the advantage of less respiratory depression (<1%) besides its good analgesic effect [13, 14] .
Administration of analgesics by the oral route in patients with renal colic is not the most recommended route, because these patients might have nausea and because of its slower analgesic effect. So the preferred route is parenteral, either intravenously (IV) or intramuscularly (IM). The IM route has theoretically the advantage of not requiring monitoring and thus can be administered quickly even in a crowded ED. The aim of our study was to compare the efficacy of intramuscular Diclofenac and Tramadol in the treatment of renal colic in the ED.
MATERIALS AND METHODS
The study site was a university general hospital with 60,000 admissions a year to the ED. From June 2007 until January 2009, one hundred patients with a clinical diagnosis of renal colic were assigned to the study. The study was approved by the ethical Helsinki Committee of our hospital.
Inclusion criteria were at least 18 years of age (and less than 65 years), ability to provide written informed consent and confirmed diagnosis of ureteral calculus.
Exclusion criteria were: allergy to the study drugs, peptic ulcer disease, renal failure, diabetes, hypertension, pregnant and breast feeding women. Patients, who got analgesics up to six hours before admission, were also excluded due to the potential effect of masking the pains.
Every patient completed the process of informed consent, and was randomly assigned to one of the two study groups. Randomization was accomplished by using the pair or unpair last digit of the ID number. Participants were randomized and treated based upon clinical evaluation and prior to the confirmatory CT scan.
CT scans were performed with a 16-slice CT scanner (LightSpeed, GE Healthcare, and Milwaukee, WI) using standard parameters for abdominal CT. Neither oral nor IV contrast material was administered. Radiologic evaluation included the degree of hydronephrosis, maximal stone size and stone location, as these parameters thought to have correlation with the intensity of pain.
Each patient, was asked to rate the initial intensity of pain on a Visual Analogue Score (VAS) from 1 to 10 [8] . Only patients with moderate to severe pain (VAS score 4) were included.
The patients were randomized to receive equi-analgesic doses of the study drugs; either IM Diclofenac 75mg (group 1) or IM Tramadol 100mg (group 2). Pain was evaluated at two points -before administration of study medication and 30 minutes after. This evaluation mostly was done by doctors that were blinded to treatment assignment.
When pain control was not achieved (less than 50% reduction in VAS score) rescue analgesia with intravenous morphine was administered. The dose of morphine given was 0.1mg/kg.
Statistical Analysis
The sample size was calculated according to the assumption that patients treated with Diclofenac will have at least 80% good response (more than 50% in pain reduction) and that patients treated with Tramadol will have 60% good response. Accordingly the sample size was calculated to achieve a statistical power of 80% at 5% type I error with 50 subjects being required for each group. To calculate the difference; t test was used for variables. For categorical variables we used the 2 test. As well we used ANCOVA and logistic regression to compare the influence of few variables on VAS.
RESULTS

Patients Characteristics
Of the 100 patients who were randomized, 97 completed the study (the other 3 patients which 2 of them received Diclofenac and the other one Tramadol -could not be included in the analysis due to lack of accurate pain estimation. Forty eight patients received Diclofenac (group 1) and forty nine subjects received Tramadol (group 2). All outcomes were evaluated during patients' stay in the ED. No significant side effects were reported in either group. Fig. (1) . The percentage of patients responded to the study drugs. 
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Mean patient's age was 37 ± 10 years in group 1 and 37 ± 11 years in group 2 (The total mean age: was 37 ± 10 (18-65 years)
The Male / Female ratio was 4:1 for group 1 and 5:2 for group 2 (Total ratio 3:1).
Baseline createnine level was 92 ± 17 (normal range 60-110mmol/l) for both groups.
The averaged VAS score at presentation was 8.7 ± 1.6 for group 1 and 8.7 ± 1.2 for group 2 (total average-8.7 ± 1.5)
Pain Reduction
Relief of pain was observed in 64% of patients treated with Diclofenac and in 49% of patients treated with Tramadol (P < 0.05) (Fig. 1) . The delta pain reduction was higher in the patients treated with Diclofenac as compared to the patients treated with Tramadol in an average of 17% ( Table  1) .
Thus; more patients in the Tramadol group were needed to be treated with rescue analgesia (P < 0.05), as shown in Fig. (2) . These findings were statistically significant.
Radiological Results
The radiological analysis was done by senior radiologist according to the radiological standards. Most of the patients in both groups had mild hydronephrosis 88% and 76% in Diclofenac and Tramadol group respectively. This difference was not statistically significant (Figs. 3, 4) .
Stone size was divided to two categories by a cut point of 4mm. a similar proportions in the two groups had stones > Fig. (2) . The percentage of patients who needed rescue analgesia. Fig. (3) . Regarding the stone's location, the proportions of stones in the Diclofenac group were 2%, 54%, 27%, 17% in the uretero-pelvic junction (UPJ), ureter, uretero-vesical junction (UVJ) and bladder respectively. In the Tramadol group the proportions were: 4%, 47%, 37%, and 12% in the same order. There was no statistically significant change between the two groups.
DISCUSSION
Both NSAIDs and opioids have traditionally been used for pain control in patients with acute renal colic.
Prospective randomized controlled studies suggest that NSAIDs are at least as effective as opiates [15, 16] .
Tramadol was found effective, well tolerated agent to reduce pain resulting from renal colic. Tramadol appears to produce less constipation and respiratory depression than equi-analgesic doses of strong opioids [3] .
One study evaluated the analgesic effect of Ketorolac versus Tramadol [17] . Both Ketorolac IM and Tramadol SC were found to be effective in the initial treatment of renal colic. Both drugs had an efficacy greater than 80%. The analgesic effect of Ketorolac is observed earlier than that of Tramadol. This last result could be secondary to the different route of administration.
To our knowledge there were no prior studies comparing NSAIDs drug and Tramadol given in the same route in the setting of analgetic treatment in renal colic.
According to our results intramuscular Diclofenac as a single agent for the treatment of renal colic appears to be more effective than intramuscular Tramadol. The beneficial effect of Diclofenac was not influenced by the presence of hydronephrosis or its degree of severity, neither by the location or size of the calculus. All these variables were similar between both groups of treatment.
Another difference between our study and others is the way we assessed pain relief. In our study we determined response as pain reduction of at least 50% from baseline before drug administration. Other studies used the quantitative VAS score reduction [18] . More than 2 VAS score reduction from baseline was used to identify good response. We retrospectively analyzed our results according to this method. The revised results showed: response rate of 87.5% in the Diclofenac group and only 61.2% response rate in the Tramadol group. These results strengthen our original results ( Table 2 ).
The study carries several limitations:
1) The relatively small number of research cases limits the statistical validity of some findings. A larger study would be required to examine important subgroups and complications For example. Subgroup analysis by stone size. This study was not powered enough to look at the subgroups by stone size. There would be an added benefit to repeating the study on a larger scale.
2) Time window -though the peak effect of the two drugs when given intramuscularly is similar theoretically variabilities in individual pharmacodynamics could affect the results [19] . Fig. (4) . The degree of Hydronephrosis in Tramadol treated patients. 
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3) The study population seems to be more resistant to pain treatment -the effect of Diclofenac on pain control has been reported to be about 80% [17] . In our population the effect was only 64%. So the results with Tramadol (49% -good clinical pain response) in our population may be actually better than it seems.
CONCLUSIONS
In our study, IM Diclofenac proved to be superior to Tramadol for pain relief in patients with renal colic. Tramadol could be used as an alternative when contraindications preclude the use of Diclofenac, although in our study, less than half of the subjects treated with Tramadol achieved good pain control as defined in this study.
